These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13881298)

  • 1. Propionyl erythromycin ester lauryl sulfate in the treatment of treponematosis and chancroid.
    CORDERO FA
    Antibiot Chemother (Northfield); 1961 Dec; 11():764-71. PubMed ID: 13881298
    [No Abstract]   [Full Text] [Related]  

  • 2. [USE OF LAURYL SULFATE OF THE PROPIONIC ESTER OF ERYTHROMYCIN IN THE ORAL TREATMENT OF EARLY SYPHILIS AND OF CHANCROID].
    CORDERO FA
    Rev Col Med Guatem; 1963 Dec; 14():154-60. PubMed ID: 14125656
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies of propionyl erythromycin lauryl sulfate in children.
    REICHELDERFER TE; BAIRD RL; OSSOFSKY HJ
    Antibiot Annu; 1959-1960; 7():899-903. PubMed ID: 14437052
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the blood levels obtained with 2 new esters of erythromycin: propionyl erythromycin and propionyl erythromycin lauryl sulfate].
    VIALLIER J; OLLAGNIER C; RONDELET J; AUGAGNEUP J
    Therapie; 1961; 16():878-95. PubMed ID: 13925737
    [No Abstract]   [Full Text] [Related]  

  • 5. The ratio of antimicrobial activity between propionyl erythromycin lauryl sulfate and erythromycin ethyl carbonate.
    GRIFFITH RS
    Antibiot Chemother (Northfield); 1961 Sep; 11():555-9. PubMed ID: 13901862
    [No Abstract]   [Full Text] [Related]  

  • 6. Further pharmacological studies on propionyl erythromycin ester lauryl sulfate.
    LEE CC; ANDERSON RC; STEPHENS VC
    Antibiot Chemother (Northfield); 1961 Feb; 11():110-7. PubMed ID: 13760219
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology and toxicology of propionyl erythromycin ester lauryl sulfate.
    ANDERSON RC; LEE CC; WORTH HM; HARRIS PN
    J Am Pharm Assoc Am Pharm Assoc; 1959 Nov; 48():623-8. PubMed ID: 13848813
    [No Abstract]   [Full Text] [Related]  

  • 8. Demonstration by "challenge" of hepatic dysfunction associated with propionyl erythromycin ester lauryl sulfate.
    ROBINSON MM
    Antibiot Chemother (Northfield); 1962 Mar; 12():147-51. PubMed ID: 14492925
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic hepatitis caused by propionyl erythromycin ester of lauryl sulfate.
    JOHNSON DF; HALL WH
    N Engl J Med; 1961 Dec; 265():1200-2. PubMed ID: 14452017
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on propionyl erythromycin lauryl sulfate (PELS)].
    KATO Y; SAITO A; NAKAYAMA I; CHIBA A; TOMIZAWA M; SHIBAKI H
    J Antibiot B; 1962 Oct; 15():300-2. PubMed ID: 14042115
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxic jaundice due to propionyl erythromycin ester lauryl sulphate ("Ilosone").
    REED C; RITCHIE F
    Med J Aust; 1962 May; 49(i)():810-2. PubMed ID: 14037477
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate.
    ROBINSON MM
    Am J Med Sci; 1962 Apr; 243():502-10. PubMed ID: 14492926
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral erythromycin in the treatment of early syphilis.
    MOORE MB; VANDERSTOEP EM; KNOX JM; MONTGOMERY CH
    J Invest Dermatol; 1962 May; 38():285-8. PubMed ID: 14475693
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of early syphilis with erythromycin.
    GREAVES AB
    Public Health Rep (1896); 1961 Oct; 76(10):929-32. PubMed ID: 13901357
    [No Abstract]   [Full Text] [Related]  

  • 15. [SUCESSFUL TREATMENT OF PYODERMA WITH PROPIONYL ERYTHROMYCIN LAURYL SULFATE].
    ABE T; KATO T; SUGANO H
    Hifuka Kiyo; 1963 Jan; 58():53-7. PubMed ID: 14045191
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of propionyl erythromycin lauryl sulfate (S6003)].
    AZUMA I; ABE K; SEO F; KAWAGUCHI S
    Nihon Ganka Kiyo; 1961 Jul; 12():658-64. PubMed ID: 13863582
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical use of propionyl erythromycin lauryl sulfate].
    TACHIBANA K; ODA S; UEO H
    Hifuka Kiyo; 1961 Sep; 56():259-65. PubMed ID: 13918855
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatosensitization caused by propionyl erythromycin lauryl sulfate.
    GUEVIN R; TEN PAS A
    Henry Ford Hosp Med Bull; 1963 Mar; 11():77-81. PubMed ID: 13951167
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythromycin in treatment of early syphilis.
    MONTGOMERY CH; KNOX JM; SCIPLE GW; VANDER STOEP EM
    Arch Intern Med; 1961 May; 107():732-5. PubMed ID: 13772194
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and in vitro efficacy of propionyl erythromycin ester.
    LIMSON BM; ARAGON PR
    Antibiotic Med Clin Ther (New York); 1960 Oct; 7():623-36. PubMed ID: 13762200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.